141 related articles for article (PubMed ID: 24393669)
1. Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model.
Julander JG; Thibodeaux BA; Morrey JD; Roehrig JT; Blair CD
Antiviral Res; 2014 Mar; 103():32-8. PubMed ID: 24393669
[TBL] [Abstract][Full Text] [Related]
2. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
[TBL] [Abstract][Full Text] [Related]
3. A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.
Thibodeaux BA; Garbino NC; Liss NM; Piper J; Schlesinger JJ; Blair CD; Roehrig JT
Antiviral Res; 2012 Apr; 94(1):1-8. PubMed ID: 22366350
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
Julander JG; Testori M; Cheminay C; Volkmann A
Front Immunol; 2018; 9():1756. PubMed ID: 30116244
[TBL] [Abstract][Full Text] [Related]
5. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.
Julander JG; Trent DW; Monath TP
Vaccine; 2011 Aug; 29(35):6008-16. PubMed ID: 21718741
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
Doyle MP; Genualdi JR; Bailey AL; Kose N; Gainza C; Rodriguez J; Reeder KM; Nelson CA; Jethva PN; Sutton RE; Bombardi RG; Gross ML; Julander JG; Fremont DH; Diamond MS; Crowe JE
mBio; 2022 Jun; 13(3):e0051222. PubMed ID: 35420472
[TBL] [Abstract][Full Text] [Related]
7. BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model.
Julander JG; Bantia S; Taubenheim BR; Minning DM; Kotian P; Morrey JD; Smee DF; Sheridan WP; Babu YS
Antimicrob Agents Chemother; 2014 Nov; 58(11):6607-14. PubMed ID: 25155605
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
[TBL] [Abstract][Full Text] [Related]
9. A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.
Thibodeaux BA; Garbino NC; Liss NM; Piper J; Blair CD; Roehrig JT
Vaccine; 2012 May; 30(21):3180-7. PubMed ID: 22425792
[TBL] [Abstract][Full Text] [Related]
10. Activity of T-1106 in a hamster model of yellow Fever virus infection.
Julander JG; Furuta Y; Shafer K; Sidwell RW
Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
Ricciardi MJ; Rust LN; Pedreño-Lopez N; Yusova S; Biswas S; Webb GM; Gonzalez-Nieto L; Voigt TB; Louw JJ; Laurino FD; DiBello JR; Raué HP; Barber-Axthelm AM; Chun K; Uttke S; Raphael LMS; Yrizarry-Medina A; Rosen BC; Agnor R; Gao L; Labriola C; Axthelm M; Smedley J; Julander JG; Bonaldo MC; Walker LM; Messaoudi I; Slifka MK; Burton DR; Kallas EG; Sacha JB; Watkins DI; Burwitz BJ
Sci Transl Med; 2023 Mar; 15(689):eade5795. PubMed ID: 36989376
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir efficacy against yellow fever in a hamster model.
Julander JG; Bunyan E; Jordan R; Porter DP
Antiviral Res; 2022 Jul; 203():105331. PubMed ID: 35533777
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.
Julander JG; Morrey JD; Blatt LM; Shafer K; Sidwell RW
Antiviral Res; 2007 Feb; 73(2):140-6. PubMed ID: 17049380
[TBL] [Abstract][Full Text] [Related]
14. Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.
Ma J; Yakass MB; Jansen S; Malengier-Devlies B; Van Looveren D; Sanchez-Felipe L; Vercruysse T; Weynand B; Javarappa MPA; Quaye O; Matthys P; Roskams T; Neyts J; Thibaut HJ; Dallmeier K
EBioMedicine; 2022 Sep; 83():104240. PubMed ID: 36041265
[TBL] [Abstract][Full Text] [Related]
15. Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus).
Rodrigues SG; da Rosa AP; Galler R; Barros VL; Vieira Cde M; da Rosa JF; Azevedo Rdo S; Nunes MR; da Rosa ES; Vasconcelos PF
Rev Soc Bras Med Trop; 2004; 37 Suppl 2():69-74. PubMed ID: 15586900
[TBL] [Abstract][Full Text] [Related]
16. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
[TBL] [Abstract][Full Text] [Related]
17. Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model.
Julander JG; Ennis J; Turner J; Morrey JD
Antimicrob Agents Chemother; 2011 May; 55(5):2067-73. PubMed ID: 21300837
[TBL] [Abstract][Full Text] [Related]
18. Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
Tottey S; Shoji Y; Jones RM; Chichester JA; Green BJ; Musiychuk K; Si H; Manceva SD; Rhee A; Shamloul M; Norikane J; Guimarães RC; Caride E; Silva ANMR; Simões M; Neves PCC; Marchevsky R; Freire MS; Streatfield SJ; Yusibov V
Am J Trop Med Hyg; 2018 Feb; 98(2):420-431. PubMed ID: 29231157
[TBL] [Abstract][Full Text] [Related]
19. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
[TBL] [Abstract][Full Text] [Related]
20. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
